Target intelligence / Profile preview

Polysynaptic pathways in the spinal cord (PSPS)

Target
PSPS
Molecular classification
Neural circuit, Interneuronal network, Physiological pathway
01

Overview

Polysynaptic pathways in the spinal cord represent complex neural circuits consisting of one or more interneurons interposed between a sensory (afferent) neuron and a motor (efferent) neuron. Unlike monosynaptic reflexes, these pathways allow for significant integration, divergence, and convergence of signals, facilitating sophisticated motor responses such as the flexor withdrawal reflex and the modulation of muscle tone (PubMed, 2021). These circuits are essential for coordinated movement but can become pathological following central nervous system injury, leading to clinical manifestations like spasticity and hyperreflexia (StatPearls, 2023). Pharmacological intervention typically focuses on depressing the excitability of these polysynaptic arcs to alleviate muscle spasms and pain. Central muscle relaxants, such as baclofen and tizanidine, exert their effects by targeting specific receptors (GABA-B and Alpha-2 adrenergic, respectively) located on the interneurons within these pathways (NIH, 2022). While not a single molecular target, the modulation of these pathways remains a cornerstone in the management of neurological disorders involving motor dysfunction.

Other names
Polysynaptic reflex arcSpinal interneuronal circuitsMultisynaptic spinal pathwaysPolysynaptic spinal reflexes
02

Mechanism of action

Drugs modulate these pathways by acting as agonists at inhibitory receptors (GABA-B or Alpha-2 adrenergic) or by increasing GABAergic inhibition, thereby reducing the excitability of spinal interneurons and alpha motor neurons (StatPearls, 2023; NIH, 2022).

03

Biological functions

Motor controlWithdrawal reflexSensory processingProprioceptionNociceptive transmissionModulation of muscle tone
04

Disease associations

SpasticityChronic painSpinal cord injuryMuscle spasmsMultiple sclerosisUpper motor neuron syndrome
05

Safety considerations

SedationMuscle weaknessDizzinessWithdrawal syndromeHepatotoxicity (specific to certain agents like tizanidine)Respiratory depression
06

Interacting drugs

Baclofen

5 more in the full profile.

07

Biomarkers

H-reflexF-wave latencyElectromyography (EMG) activityAshworth Scale (clinical assessment of spasticity)

Beyond the preview

Go deeper on Polysynaptic pathways in the spinal cord (PSPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polysynaptic pathways in the spinal cord (PSPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call